MyAverix Finance
F · Healthcare
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (R9Z)
Biotechnology
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (R9Z) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $206.17M, P/E ratio is 18.00, net margin is -141.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for R9Z
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (R9Z) — FAQ
What is ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'s market cap?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (R9Z) has a reported market cap of $206.17M (data as of 2026-03-30).
What is R9Z's P/E ratio?
The price-to-earnings (P/E) ratio for ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (R9Z) is 18.00 (data as of 2026-03-30).
Does ImmuneOnco Biopharmaceuticals (Shanghai) Inc. pay a dividend?
Dividend yield is not available in the current snapshot for ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (R9Z). Check the MyAverix Finance app for the latest dividend data.
What sector is ImmuneOnco Biopharmaceuticals (Shanghai) Inc. in?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (R9Z) is classified in the Healthcare sector (Biotechnology industry).
What exchange is R9Z listed on?
R9Z is listed on F.
What is ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'s net margin?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (R9Z) reports a net margin of -141.7% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.